Search by Drug Name or NDC
NDC 58809-0999-01 VANACOF 12.5; 1; 30 mg/5mL; mg/5mL; mg/5mL Details
VANACOF 12.5; 1; 30 mg/5mL; mg/5mL; mg/5mL
VANACOF is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE.
Product Information
| NDC | 58809-0999 |
|---|---|
| Product ID | 58809-999_02e794d3-e6b6-8ee7-e063-6394a90ab69d |
| Associated GPIs | 43995803630920 |
| GCN Sequence Number | 064077 |
| GCN Sequence Number Description | dexchlorphenir/pse/chlophedian LIQUID 1-30-12.5 ORAL |
| HIC3 | B3R |
| HIC3 Description | NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST |
| GCN | 99788 |
| HICL Sequence Number | 035643 |
| HICL Sequence Number Description | DEXCHLORPHENIRAMINE MALEATE/PSEUDOEPHEDRINE/CHLOPHEDIANOL |
| Brand/Generic | Brand |
| Proprietary Name | VANACOF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 1; 30 |
| Active Ingredient Units | mg/5mL; mg/5mL; mg/5mL |
| Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Labeler Name | GM Pharmaceuticals, INC |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58809-0999-01 (58809099901)
| NDC Package Code | 58809-999-01 |
|---|---|
| Billing NDC | 58809099901 |
| Package | 473 mL in 1 BOTTLE (58809-999-01) |
| Marketing Start Date | 2008-04-22 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.09755 |
| Pricing Unit | ML |
| Effective Date | 2022-05-18 |
| NDC Description | VANACOF LIQUID |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis